InflaRx (IFRX) Short Interest Ratio & Short Volume $2.04 +0.12 (+6.25%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends InflaRx Short Interest DataInflaRx (IFRX) has a short interest of 168,000 shares. This marks a -30.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 250,572 shares to cover all short positions.Current Short Interest168,000 sharesPrevious Short Interest241,700 sharesChange Vs. Previous Month-30.49%Dollar Volume Sold Short$260,400.00Short Interest Ratio2.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares58,880,000 sharesPercentage of Shares Shorted0.29%Today's Trading Volume370,130 sharesAverage Trading Volume250,572 sharesToday's Volume Vs. Average148% Short Selling InflaRx? Sign up to receive the latest short interest report for InflaRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIFRX Short Interest Over TimeIFRX Days to Cover Over TimeIFRX Percentage of Float Shorted Over Time Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. InflaRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024168,000 shares $260,400.00 -30.5%N/A2.3 $1.55 10/15/2024241,700 shares $357,716.00 -8.1%N/A3.4 $1.48 9/30/2024262,900 shares $402,237.00 +63.2%N/A4.4 $1.53 9/15/2024161,100 shares $230,373.00 -26.6%N/A2.3 $1.43 8/31/2024219,400 shares $348,846.00 -3.6%N/A3.1 $1.59 8/15/2024227,600 shares $307,260.00 -9.2%N/A2.3 $1.35 Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024250,600 shares $375,900.00 +281.4%N/A1.9 $1.50 7/15/202465,700 shares $109,062.00 -71.8%N/A0.5 $1.66 6/30/2024232,800 shares $405,072.00 +151.1%N/A1.3 $1.74 6/15/202492,700 shares $144,612.00 +233.5%N/A0.5 $1.56 5/31/202427,800 shares $39,754.00 -61.3%N/A0.1 $1.43 5/15/202471,800 shares $100,520.00 -45.4%N/A0.3 $1.40 4/30/2024131,500 shares $180,155.00 +2.9%N/A0.6 $1.37 4/15/2024127,800 shares $177,642.00 -67.2%N/A0.6 $1.39 3/31/2024389,100 shares $599,214.00 +22.9%N/A1.7 $1.54 3/15/2024316,700 shares $500,386.00 +7.8%N/A1.2 $1.58 2/29/2024293,900 shares $523,142.00 -9.4%N/A1.1 $1.78 2/15/2024324,200 shares $499,268.00 +5.6%N/A1.2 $1.54 1/31/2024307,000 shares $497,340.00 -19.5%N/A1.2 $1.62 1/15/2024381,200 shares $659,476.00 -18.2%N/A0.9 $1.73 12/31/2023466,200 shares $759,906.00 -26.1%N/A1.1 $1.63 12/15/2023631,200 shares $826,872.00 -7.9%N/A1.7 $1.31 11/30/2023685,300 shares $925,155.00 +1.9%N/A2.1 $1.35 11/15/2023672,500 shares $975,125.00 +298.9%N/A2.1 $1.45 10/31/2023168,600 shares $284,934.00 +81.5%N/A0.5 $1.69 10/15/202392,900 shares $217,386.00 -10.8%N/A0.5 $2.34 9/30/2023104,200 shares $310,516.00 -46.1%N/A0.6 $2.98 9/15/2023193,300 shares $730,674.00 +2.8%N/A1.1 $3.78 8/31/2023188,100 shares $742,995.00 -33.1%N/A0.9 $3.95 8/15/2023281,300 shares $970,485.00 -12.2%N/A1.2 $3.45 7/31/2023320,300 shares $1.34 million +5.3%N/A1.3 $4.19 7/15/2023304,100 shares $1.26 million -15.2%N/A1 $4.15 6/30/2023358,700 shares $1.60 million -44.7%N/A0.5 $4.46 6/15/2023648,500 shares $2.89 million -14.9%N/A0.3 $4.45 5/31/2023761,900 shares $3.19 million +8.0%N/A0.3 $4.19 5/15/2023705,400 shares $3.41 million -26.3%N/A0.3 $4.84 4/30/2023956,900 shares $4.66 million -49.4%2.5%0.4 $4.87 4/15/20231,890,000 shares $8.18 million +933.4%5.0%0.8 $4.33 3/31/2023182,900 shares $354,826.00 -10.3%0.5%0.1 $1.94 3/15/2023203,900 shares $364,981.00 -12.5%0.5%2.1 $1.79This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 2/28/2023233,000 shares $450,855.00 -2.2%0.6%2.3 $1.94 2/15/2023238,200 shares $521,658.00 -10.6%0.6%2.3 $2.19 1/31/2023266,400 shares $578,088.00 -12.4%0.7%2.5 $2.17 1/15/2023304,100 shares $799,783.00 -12.6%0.8%2.9 $2.63 12/30/2022348,000 shares $1.08 million -1.7%0.9%3.3 $3.10 12/15/2022354,100 shares $789,643.00 -14.8%0.9%3.5 $2.23 11/30/2022415,800 shares $1.08 million -0.5%1.1%4.5 $2.60 11/15/2022417,900 shares $1.07 million +2.1%1.1%4.3 $2.57 10/31/2022409,200 shares $1.06 million -4.1%1.1%3.5 $2.60 10/15/2022426,800 shares $1.02 million -0.4%1.1%1.2 $2.39 9/30/2022428,700 shares $1.13 million +1.4%1.1%1.2 $2.64 9/15/2022422,800 shares $1.18 million -5.4%1.1%0.7 $2.78 8/31/2022447,100 shares $988,091.00 +6.9%1.2%0.8 $2.21 8/15/2022418,300 shares $1.13 million -52.4%1.1%0.7 $2.71 7/31/2022878,400 shares $2.41 million +7.9%2.3%1.6 $2.74 7/15/2022813,800 shares $1.10 million -6.7%2.2%1.8 $1.35 6/30/2022872,400 shares $1.26 million +511.4%2.3%2.5 $1.45 6/15/2022142,700 shares $181,229.00 +9.0%0.4%0.8 $1.27 5/31/2022130,900 shares $208,131.00 +35.8%0.4%0.6 $1.59 5/15/202296,400 shares $140,744.00 -32.0%0.3%0.4 $1.46 4/30/2022141,700 shares $239,473.00 -30.9%0.4%0.6 $1.69 4/15/2022205,100 shares $369,180.00 -43.2%0.6%0.8 $1.80 3/31/2022361,000 shares $660,630.00 -30.6%N/A1.3 $1.83 3/15/2022520,500 shares $1.09 million -18.8%1.5%2.2 $2.09 2/28/2022640,600 shares $1.70 million -12.6%1.8%2.8 $2.66 2/15/2022732,500 shares $2.53 million -8.3%2.1%2.4 $3.45 1/31/2022798,400 shares $2.85 million -11.1%2.2%1.6 $3.57 1/15/2022898,500 shares $3.82 million -4.7%N/A0 $4.25 12/31/2021943,100 shares $4.49 million -17.3%2.6%0.3 $4.76 12/15/20211,140,000 shares $4.71 million +1.8%3.1%0.4 $4.13 11/30/20211,120,000 shares $5.61 million +68.0%3.1%0.4 $5.01 11/15/2021666,800 shares $3.27 million -23.2%1.8%0.2 $4.90 10/29/2021868,200 shares $3.68 million +116.0%2.4%0.3 $4.24 10/15/2021401,900 shares $992,693.00 +27.4%1.1%0.7 $2.47 9/30/2021315,500 shares $817,145.00 -13.4%0.9%1.1 $2.59 9/15/2021364,500 shares $1.01 million +212.1%1.0%1.5 $2.76 8/31/2021116,800 shares $300,176.00 -12.9%0.3%0.5 $2.57 8/13/2021134,100 shares $323,181.00 +64.3%0.4%0.8 $2.41 7/30/202181,600 shares $212,160.00 +91.6%0.2%0.4 $2.60 7/15/202142,600 shares $109,482.00 +41.1%0.1%0.2 $2.57 6/30/202130,200 shares $89,694.00 -14.5%0.1%0.1 $2.97 6/15/202135,300 shares $110,489.00 -26.3%0.1%0.1 $3.13 5/28/202147,900 shares $146,095.00 -69.8%0.1%0.2 $3.05 5/14/2021158,600 shares $431,392.00 +100.5%N/A0.4 $2.72 4/30/202179,100 shares $295,834.00 -86.8%N/A0.2 $3.74 4/15/2021598,100 shares $2.26 million +12.0%3.1%1.6 $3.78 3/31/2021533,900 shares $2.02 million +3.6%2.7%1.3 $3.79 3/15/2021515,200 shares $2.47 million +19.8%2.7%1.3 $4.79 2/26/2021430,000 shares $1.93 million -8.0%2.2%1 $4.49 2/12/2021467,200 shares $2.70 million +1.3%2.4%1.4 $5.77This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 1/29/2021461,200 shares $2.56 million +5.2%2.4%1.5 $5.54 1/15/2021438,600 shares $2.64 million +6.1%2.3%1.5 $6.03 12/31/2020413,300 shares $2.03 million -37.7%2.1%1.5 $4.91 12/15/2020663,100 shares $3.30 million +34.8%3.4%1.9 $4.98 11/30/2020492,100 shares $1.96 million +2.4%2.5%1.4 $3.98 11/15/2020480,800 shares $2.02 million -4.4%2.5%1.4 $4.20 10/30/2020503,100 shares $2.07 million -15.1%2.6%1.4 $4.12 10/15/2020592,600 shares $2.99 million +27.4%3.1%1.4 $5.05 9/30/2020465,300 shares $1.98 million +20.1%2.4%0.7 $4.26 9/15/2020387,500 shares $1.86 million -5.6%1.9%0.7 $4.80 8/31/2020410,600 shares $1.81 million -40.2%2.1%0.6 $4.40 8/14/2020686,200 shares $3.01 million -26.4%3.4%0.9 $4.38 7/31/2020932,500 shares $4.68 million +30.3%5.4%1 $5.02 7/15/2020715,700 shares $3.52 million +4.5%4.1%0.7 $4.92 6/30/2020684,800 shares $3.31 million +40.3%4.0%0.8 $4.83 6/15/2020488,000 shares $3.27 million +235.2%2.8%0.3 $6.70 5/29/2020145,600 shares $1.30 million -62.7%0.8%0.1 $8.96 5/15/2020390,600 shares $2.85 million -54.9%2.3%0.3 $7.29 4/30/2020865,100 shares $6.12 million -19.9%5.0%0.6 $7.07 4/15/20201,080,000 shares $5.67 million +66.2%6.2%0.9 $5.25 3/31/2020649,700 shares $3.79 million -27.0%3.8%0.6 $5.84 3/13/2020890,500 shares $4.50 million +2.3%5.1%0.7 $5.05 2/28/2020870,300 shares $3.00 million +18.3%5.0%1.5 $3.45 2/14/2020735,800 shares $2.75 million -16.9%4.3%1.1 $3.74 1/31/2020885,700 shares $4.30 million +8.5%4.9%1.3 $4.85 1/15/2020816,000 shares $2.62 million -21.5%4.5%1.2 $3.21 12/31/20191,040,000 shares $3.46 million -8.8%5.8%1.5 $3.33 IFRX Short Interest - Frequently Asked Questions What is InflaRx's current short interest? Short interest is the volume of InflaRx shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 168,000 shares of IFRX short. Learn More on InflaRx's current short interest. What is a good short interest ratio for InflaRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IFRX shares currently have a short interest ratio of 2.0. Learn More on InflaRx's short interest ratio. Is InflaRx's short interest increasing or decreasing? InflaRx saw a drop in short interest in October. As of October 31st, there was short interest totaling 168,000 shares, a drop of 30.5% from the previous total of 241,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InflaRx's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InflaRx: Xeris Biopharma Holdings, Inc. (7.63%), SIGA Technologies, Inc. (11.28%), Cartesian Therapeutics, Inc. (17.19%), Tango Therapeutics, Inc. (14.56%), Aura Biosciences, Inc. (2.66%), Korro Bio, Inc. (4.43%), Taysha Gene Therapies, Inc. (8.61%), Foghorn Therapeutics Inc. (3.93%), Aquestive Therapeutics, Inc. (11.12%), Verve Therapeutics, Inc. (27.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short InflaRx stock? Short selling IFRX is an investing strategy that aims to generate trading profit from InflaRx as its price is falling. IFRX shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InflaRx? A short squeeze for InflaRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IFRX, which in turn drives the price of the stock up even further. How often is InflaRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IFRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Xeris Biopharma Short Squeeze SIGA Technologies Short Squeeze Cartesian Therapeutics Short Squeeze Tango Therapeutics Short Squeeze Aura Biosciences Short Squeeze Korro Bio Short Squeeze Taysha Gene Therapies Short Squeeze Foghorn Therapeutics Short Squeeze Aquestive Therapeutics Short Squeeze Verve Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IFRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx Please log in to your account or sign up in order to add this asset to your watchlist. Share InflaRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
